Oncternal Therapeutics Stock Forecast - Daily Balance Of Power
| ONCTDelisted Stock | USD 0.53 0.00 0.00% |
Oncternal Stock Forecast is based on your current time horizon.
Oncternal |
| Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
| (1.00) | 0.6 |
| Check Oncternal Therapeutics Volatility | Backtest Oncternal Therapeutics | Trend Details |
Oncternal Therapeutics Trading Date Momentum
| On March 28 2024 Oncternal Therapeutics was traded for 9.00 at the closing time. The top price for the day was 9.25 and the lowest listed price was 8.00 . The trading volume for the day was 14.5 K. The trading history from March 28, 2024 was a factor to the next trading day price appreciation. The trading delta at closing time against the next closing price was 9.76% . The trading delta at closing time against the current closing price is 11.22% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Oncternal Therapeutics to competition
View Oncternal Therapeutics Related Equities
| Risk & Return | Correlation |
Oncternal Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Oncternal Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncternal Therapeutics shares will generate the highest return on investment. By undertsting and applying Oncternal Therapeutics stock market strength indicators, traders can identify Oncternal Therapeutics entry and exit signals to maximize returns.
Oncternal Therapeutics Risk Indicators
The analysis of Oncternal Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Oncternal Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting oncternal stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 7.09 | |||
| Standard Deviation | 12.41 | |||
| Variance | 154.07 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Oncternal Stock
If you are still planning to invest in Oncternal Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncternal Therapeutics' history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |